Our People
Implicit's Board, management team and Scientific Advisory Board are each comprised of individuals with international reputations and experience in the biotechnology and pharmaceutical industries, with demonstrated capability in managing clinical trials, research and development and drug production with skills in strategic thinking, leadership, business development, corporate governance, finance, accounting and marketing.
Management Team
- Garry Redlich - Managing Director & Chief Executive Officer
- Ian Frazer MD PhD - Chief Scientific Officer
- Dan Parry - CFO & Company Secretary
- Helen Roberts - Vice President, Antibody Therapeutics Development
- Tamsin Terry PhD - Director, Research
- Jane Andrews PhD - Director, Corporate Strategy
- Rachel Fahy - Manager, Clinical Trials
- Jay Madan - Business Development
Board of Directors
- Emeritus Professor Peter Andrews AO - Chairman
- Ian Frazer MD PhD - Chief Scientific Officer
- Garry Redlich - Managing Director & Chief Executive Officer
- Dan Syrdal PhD JD
- Rose-Anne Kelso
